Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: The clinical efficacy and adverse effects of Entecavir plus Thymosin alpha-1 combination therapy versus Entecavir Monotherapy in HBV-related cirrhosis: a systematic review and meta-analysis

Fig. 2

Relative risk of the efficacy to HBV-related patients with cirrhosis in ETV plus Tα1 group and ETV alone group. a meta-analysis for the effective response; b meta-analysis for no response. Blue boxes indicate the dichotomous data in the forest plots. CI, confidence interval; M-H, Mantel-Haensel

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us